LncRNA TMPO-AS1 suppresses the maturation of miR-335-5p to participate in polycystic ovary syndrome

BACKGROUND: TMPO-AS1 is a recently characterized oncogenic lncRNA in ovarian cancer. Its role in other ovary diseases is unknown. This study explored its role in polycystic ovary syndrome (PCOS). METHODS: Follicular fluid was extracted from both PCOS patients and controls. The levels of TMPO-AS1 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Fang, Li, Jie, Peng, Jie, Teng, Zhenghua, Feng, Jun, Xia, Weiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325176/
https://www.ncbi.nlm.nih.gov/pubmed/34330309
http://dx.doi.org/10.1186/s13048-021-00848-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325176/
https://www.ncbi.nlm.nih.gov/pubmed/34330309
http://dx.doi.org/10.1186/s13048-021-00848-3

Ejemplares similares